Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis. Unidade: FM
Assunto: ENDOCRINOLOGIA
ABNT
NAKANDAKARE, E R et al. Bezafibrate treatment of mixed lipemia modifies plasma ldl composition but not the c'U IND.2+' induced tbars production despite lowering the rate of in vitro degradation of oxidized ldl by mouse peritoneal macrophages. Atherosclerosis. Limerick: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 1994APA
Nakandakare, E. R., Carvalho, M. D. T., Lottenberg, A. M. P., Passarelli, M., Nunes, V. S., Catanozi, S., & Quintão, E. C. da R. (1994). Bezafibrate treatment of mixed lipemia modifies plasma ldl composition but not the c'U IND.2+' induced tbars production despite lowering the rate of in vitro degradation of oxidized ldl by mouse peritoneal macrophages. Atherosclerosis. Limerick: Faculdade de Medicina, Universidade de São Paulo.NLM
Nakandakare ER, Carvalho MDT, Lottenberg AMP, Passarelli M, Nunes VS, Catanozi S, Quintão EC da R. Bezafibrate treatment of mixed lipemia modifies plasma ldl composition but not the c'U IND.2+' induced tbars production despite lowering the rate of in vitro degradation of oxidized ldl by mouse peritoneal macrophages. Atherosclerosis. 1994 ;109( 1-2): 48.[citado 2024 nov. 14 ]Vancouver
Nakandakare ER, Carvalho MDT, Lottenberg AMP, Passarelli M, Nunes VS, Catanozi S, Quintão EC da R. Bezafibrate treatment of mixed lipemia modifies plasma ldl composition but not the c'U IND.2+' induced tbars production despite lowering the rate of in vitro degradation of oxidized ldl by mouse peritoneal macrophages. Atherosclerosis. 1994 ;109( 1-2): 48.[citado 2024 nov. 14 ]